Robert J. Mulroy, President and CEO at MERRIMACK PHARMACEUTICALS INC (MACK), bought 33,100 shares at $4.42 ($146K) on 2013-12-04, disclosed to the SEC on 2013-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MACK | SELL | 2015-02-20 | $1.6M | — | Filing → |
| MACK | SELL | 2014-12-09 | $2.0M | — | Filing → |
| MACK | BUY | 2014-05-07 | $32K | — | Filing → |